Paul Hopper
CIK: 0002045367
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
RADX
Radiopharm Theranostics Ltd
Director
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About HOPPER PAUL
HOPPER PAUL (SEC CIK 0002045367) files insider reports with the SEC as Director of Radiopharm Theranostics Ltd (RADX).
Signal8 holds 1 ownership filing by HOPPER PAUL, a Form 3, filed on May 6, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on HOPPER PAUL's filings is in CARLTON SOUTH, VICTORIA.
Other insiders filing for Radiopharm Theranostics Ltd (RADX)
- Voliotis Dimitris, Chief Medical Officer
- Donnelly Noel, Director
- Turner Ian Lawrence, Director
- Goodwin Bruce Michael, Director